DHEA Debate Returns To Fore: Anabolic Steroid Status Sought In Grassley Bill
This article was originally published in The Tan Sheet
Executive Summary
A new bill sponsored by Sen. Charles Grassley (R-Iowa) would regulate dehydroepiandrosterone (DHEA) as an anabolic steroid under the Controlled Substances Act
You may also be interested in...
Grassley’s Swing At Illegal Anabolic Steroid Use Unfairly Strikes DHEA – CRN
Legislation introduced in response to a report on steroid use in Major League Baseball that would put an age restriction on sales of performance-enhancing drugs and supplements - including DHEA - is a "misdirected attempt ... based on emotional rhetoric" to curb illegal anabolic steroid use, industry leaders say
DHEA bill returns
Sen. Chuck Grassley, R-Iowa, on March 5 reintroduces a bill to list dehydroepiandrosterone as an anabolic steroid under the Controlled Substances Act. Co-sponsored by Sens. Dick Durbin, D-Ill. and John McCain, R-Ariz., S. 762 has been referred to the Judiciary Committee. In a same day release, Grassley says DHEA has "a number of potential long-term physical and psychological effects" including heart disease, cancer, stroke and liver damage. Industry groups maintain DHEA has little to no potential for abuse. Grassley previously introduced the measure in 2005 (1"The Tan Sheet" June 6, 2005, p. 11)...
Trade Groups Make AER Legislation Wish List; Preemption Is Top Priority
Federal legislation requiring mandatory adverse event reporting for dietary supplements is both "likely" and "good" but must include preemption of state laws, trade groups asserted during a "State of the Industry" seminar Nov. 11 at SupplySide West in Las Vegas